Immunovant (NASDAQ:IMVT) Coverage Initiated at Jefferies Financial Group

Jefferies Financial Group assumed coverage on shares of Immunovant (NASDAQ:IMVT – Free Report) in a research note issued to investors on Monday morning, MarketBeat Ratings reports. The firm issued a hold rating and a $20.00 price target on the stock. Several other research firms have also recently commented on IMVT. Wolfe Research cut shares of […]

Leave a Reply

Your email address will not be published.

Previous post Colgate-Palmolive (NYSE:CL) Rating Increased to Buy at StockNews.com
Next post Redburn Atlantic Begins Coverage on Enphase Energy (NASDAQ:ENPH)